Read safety information Supporting research A selection of peer-reviewed work on AOD 9604/MOTS-C
Tuy nhin, i vi nhng ngi c tnh trng thiu ht ko di th c th mt t vi tun n vi thng thy c kt qu r rt
(2017) Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial Janet Vittone, et al
In Progress (2025): California, Massachusetts, Illinois, Virginia, Texas and New Hampshire have introduced or reintroduced similar legislation targeting underage access to performance-enhancing supplements
Subjects enrolled were also negative for HIV and had no history of latent tuberculosis infection or liver function abnormalities
Alternate injection sites include the outer thigh or upper arm fatty tissue if rotating sites to prevent lipohypertrophy (tissue buildup from repeated injections)